Co-Diagnostics, Inc.CODXNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -73.91% | -95.80% | -80.11% | -93.87% | -77.32% |
| Gross Profit Growth | -84.38% | -118.00% | +57.28% | -94.65% | -65.35% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +3.86% | +5.74% | +7.39% | +9.90% | +24.26% |
| Weighted Average Shares Diluted Growth | +3.86% | +5.74% | +7.39% | +9.90% | +24.26% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -91.39% | -59.93% | -68.64% | -61.75% | +449.32% |
| Inventory Growth | -71.99% | -35.56% | -30.10% | -25.91% | -13.91% |
| Asset Growth | -33.40% | -32.86% | -36.37% | -42.42% | -38.19% |
| Book Value per Share Growth | -38.27% | -40.28% | -43.05% | -48.30% | -49.75% |
| Debt Growth | -22.20% | -28.03% | -30.81% | -34.01% | -37.86% |
| R&D Expense Growth | -15.69% | -22.20% | -14.26% | -16.48% | -8.19% |
| SG&A Expenses Growth | +5.84% | +12.10% | -23.48% | -23.10% | -55.40% |